Arkolith/Insider Trading/AXSM/Form 4

Jacobson Mark L.

Chief Operating OfficerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed May 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)233$12.95$3K233
May 5, 2026Sell(S)233$228.18$53K0
May 4, 2026Option exercise(M)5K$12.95$58K5K
May 4, 2026Sell(S)5K$227.94$1.0M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)233—$0115K
May 4, 2026Option exercise(M)5K—$0115K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-207148) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML